Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chordomas”

75 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 75 results

Testing effectiveness (Phase 2)Study completedNCT03623854
What this trial is testing

Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma

Who this might be right for
ChordomaLocally Advanced ChordomaMetastatic Chordoma+1 more
Jonsson Comprehensive Cancer Center 10
Not applicableActive Not RecruitingNCT04087902
What this trial is testing

Long-Term Longitudinal QoL in Patients Undergoing EEA

Who this might be right for
Pituitary TumorMeningiomaRathke Cleft Cysts+5 more
Ohio State University 400
Not applicableLooking for participantsNCT05861245
What this trial is testing

Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base

Who this might be right for
ChordomaChondrosarcoma
Quironsalud 20
Not applicableStudy completedNCT01347307
What this trial is testing

Stereotactic Body Radiotherapy for Spine Tumors

Who this might be right for
Spinal MetastasesVertebral MetastasesBenign Spinal Tumors+6 more
Mercy Research 38
Early research (Phase 1)Ended earlyNCT02936102
What this trial is testing

FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.

Who this might be right for
Advanced Solid TumorsTriple Negative Breast CancerChordoma and Alveolar Soft Part Sarcoma
Novartis Pharmaceuticals 154
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Large-scale testing (Phase 3)UnknownNCT01182779
What this trial is testing

Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Chordoma of the Skull Base

Who this might be right for
ChordomaTumorTreatment
Heidelberg University 319
Testing effectiveness (Phase 2)Study completedNCT02802969
What this trial is testing

Improvement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT Tracers

Who this might be right for
Skull Base ChordomaVertebral Chordoma
Institut Curie 64
Testing effectiveness (Phase 2)Study completedNCT02383498
What this trial is testing

QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma

Who this might be right for
Chordoma
NantCell, Inc. 24
Early research (Phase 1)Ended earlyNCT00003926
What this trial is testing

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorChordoma+6 more
Masonic Cancer Center, University of Minnesota 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT06957327
What this trial is testing

ERAS-601 in People With Chordoma

Who this might be right for
Chordoma
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)UnknownNCT01811394
What this trial is testing

Ion Irradiation of Sacrococcygeal Chordoma

Who this might be right for
Sacral Chordoma
Heidelberg University 100
Not applicableStudy completedNCT06535997
What this trial is testing

Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILE

Who this might be right for
CancerCystic Carcinomas, AdenoidSoft-tissue Sarcomas+6 more
Hospices Civils de Lyon 62
Not applicableLooking for participantsNCT05033288
What this trial is testing

Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone

Who this might be right for
Bone SarcomaChondrosarcomaChordoma+2 more
Mayo Clinic 72
Testing effectiveness (Phase 2)Study completedNCT03110744
What this trial is testing

CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma

Who this might be right for
Chordoma
University Hospital Heidelberg 43
Testing effectiveness (Phase 2)Study completedNCT03083678
What this trial is testing

Afatinib in Locally Advanced and Metastatic Chordoma

Who this might be right for
Chordoma
Leiden University Medical Center 43
Early research (Phase 1)Active Not RecruitingNCT02989636
What this trial is testing

Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma

Who this might be right for
Chordoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT04416568
What this trial is testing

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

Who this might be right for
Malignant Rhabdoid TumorRhabdoid Tumor of the KidneyEpithelioid Sarcoma+4 more
Dana-Farber Cancer Institute 45
Not applicableLooking for participantsNCT02838602
What this trial is testing

Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors

Who this might be right for
Malignant Tumors as Chordoma, Adenoid Cystic Carcinoma and Sarcoma
Hospices Civils de Lyon 250
Load More Results